Publication | Closed Access

Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run

Radiation MedicineUrologyHealth SciencesMedicineCancer ManagementClinical TrialsEortc TrialPharmacotherapyPhase Iii StudyCancer TreatmentProstatic DiseaseOncologyRadiation OncologyLhrh Analogue